Paid Clinical Trials and Focus Groups by Location |
|
|
|
Condition: Idiopathic Menorrhagia
Interventions: Drug: Levonorgestrel (Mirena, BAY86-5028); Drug: Hormonal treatment; Drug: Antifibrinolytic treatment
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Ovulation Induction
Intervention: Drug: Recombinant FSH (follitropin alpha)
Sponsor: Merck KGaA
Recruiting - verified March 2010